Genesco (GCO) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 Jul, 2026Executive summary
Net sales rose to $474 million, up 4% year-over-year, with comparable sales up 5% and e-commerce accounting for 23% of retail sales, led by Journeys' 8% comp increase and continued market share gains.
All channels posted positive growth: stores up mid-single digits, online up 7%, and wholesale up 5%.
Operating income and EPS improved year-over-year, driven by higher sales and expense leverage from cost reduction efforts.
Top and bottom-line results exceeded expectations, and full-year EPS guidance was reaffirmed despite tariff and macroeconomic uncertainties.
Consumer environment remains choppy, but compelling assortments and strategic initiatives are driving performance.
Financial highlights
Gross margin was 46.7%, down 60–90 basis points year-over-year, mainly due to higher athletic mix and promotional activity.
SG&A expense was $249 million, 52.5% of sales, leveraging 170 basis points year-over-year.
Adjusted operating loss was $27.9 million, improved from $30 million loss last year; adjusted diluted loss per share was $2.05 vs. $2.10 last year.
Adjusted EBITDA loss was $14.5 million, or -3.1% of sales, improved from $16.7 million last year.
Inventory increased 15% year-over-year to $451 million to support Journeys growth.
Outlook and guidance
Fiscal 2026 adjusted EPS guidance reiterated at $1.30–$1.70, including current tariffs.
Total sales expected to rise 1%–2% year-over-year, with comparable sales up 2%–3%.
Gross margin expected down 20–30 basis points for the year, offset by mitigation and retail margin improvement.
Q2 sales expected slightly above last year, with positive Journeys comps offset by softness in other segments and store closures.
Higher interest costs and tax rate (~29%) expected; positive free cash flow anticipated for the full year.
Latest events from Genesco
- Proxy advisors unanimously back all nine directors, supporting current strategy and board oversight.GCO
Proxy filing - Board urges support for its refreshed, diverse slate to sustain strategic momentum and value.GCO
Proxy filing - ISS backs all nine incumbent nominees in a contested board election ahead of the Annual Meeting.GCO
Proxy filing - ISS backs all nine incumbent directors; board urges support against dissident nominees.GCO
Proxy filing - Strong sales growth, digital gains, and board stability drive long-term value creation.GCO
Proxy filing - Shareholders are asked to support nine board nominees to maintain momentum and protect value.GCO
Proxy filing - Proxy contest seeks board refreshment and governance reform, urging votes for two independent nominees.GCO
Proxy filing - Board urges support for its nominees, citing strong results and risks from activist candidates.GCO
Proxy filing - Q3 sales and comps beat expectations, raising FY25 guidance despite a tax-driven net loss.GCO
Q3 2025